UAB "Molekulės" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 229,076 |
| 34,344 |
| 11,803 |
| 11,105 |
| 1,665 |
| 58.42 |
| 4.85 |
| 40,412 |
| 20,579 |
| 7,691 |
| 53,300 |
| 2024 |
|---|
| 241,137 |
| 39,857 |
| 12,405 |
| 11,785 |
| 1,948 |
| 53.86 |
| 4.89 |
| 52,197 |
| 19,816 |
| 12,157 |
| 59,856 |
| 2025 |
|---|
| 228,790 |
| 40,710 |
| 10,425 |
| 9,816 |
| 1,747 |
| 52.58 |
| 4.29 |
| 58,964 |
| 35,709 |
| 11,202 |
| 83,471 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 228,790 |
| 40,710 |
| 10,425 |
| 9,816 |
| 1,747 |
| 52.58 |
| 4.29 |
| 58,964 |
| 35,709 |
| 11,202 |
| 83,471 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
228,790 €-5 % *
Sales per employee (€)
40,710 €2 % *
Profit before tax (€)
10,425 €-16 % *
Net Profit (€)
9,816 €-17 % *
Profit per employee (€)
1,747 €-10 % *
Total profitability (%)
52.58 %-2.38 % *
Net profitability (%)
4.29 %-12.27 % *
Equity (€)
58,964 €13 % *
Amounts Payable And Liabilities (€)
35,709 €80 % *
Non-current Assets (€)
11,202 €-8 % *
CurrentAssets (€)
83,471 €39 % *
